PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Cancer 1,053,491 Disease Target DAPK1 205 94 0.01 -0.74 0.46 0.58
Cancer 1,053,491 Disease Disease Salivary Gland Cancer 202 202 0.01 -0.07 1.00 0.61
Cancer 1,053,491 Disease Target CD72 198 3 0.00 -0.99 0.02 0.51
Cancer 1,053,491 Disease Target CCL8 197 16 0.00 -0.96 0.08 0.54
Cancer 1,053,491 Disease Target Adp-Ribosylation Factor 1 196 7 0.00 -0.98 0.04 0.52
Cancer 1,053,491 Disease Target Aurora Kinase A 196 103 0.01 -0.69 0.53 0.59
Cancer 1,053,491 Disease Target Des (1-3) IGF-I 191 15 0.00 -0.96 0.08 0.54
Cancer 1,053,491 Disease Disease Central Nervous System Disorder 187 4 0.00 -0.99 0.02 0.51
Cancer 1,053,491 Disease Target BMX 185 32 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Target CA 72-4 184 112 0.01 -0.63 0.61 0.59
Cancer 1,053,491 Disease Target AHSG 176 16 0.00 -0.95 0.09 0.54
Cancer 1,053,491 Disease Disease Fibrocystic Breast Disease 173 65 0.00 -0.79 0.38 0.58
Cancer 1,053,491 Disease Target Arachidonate 5-Lipoxygenase 170 16 0.00 -0.95 0.09 0.54
Cancer 1,053,491 Disease Disease Alzheimers Disease 169 8 0.00 -0.98 0.05 0.53
Cancer 1,053,491 Disease Target Histamine H4 Receptor 168 4 0.00 -0.99 0.02 0.52
Cancer 1,053,491 Disease Drug Acetic Acid (Acetic Acid)- FDA 168 9 0.00 -0.97 0.05 0.53
Cancer 1,053,491 Disease Disease Orthopedic Disorders 168 5 0.00 -0.99 0.03 0.52
Cancer 1,053,491 Disease Target Complement Component C1q 167 4 0.00 -0.99 0.02 0.52
Cancer 1,053,491 Disease Disease Pruritis 158 12 0.00 -0.96 0.08 0.54
Cancer 1,053,491 Disease Disease Visual Disorder 152 9 0.00 -0.97 0.06 0.53
Cancer 1,053,491 Disease Target Carbonic Anhydrase 9 150 80 0.01 -0.68 0.53 0.59
Cancer 1,053,491 Disease Target Sphingosine 1-Phosphate Receptor 1 150 16 0.00 -0.95 0.11 0.55
Cancer 1,053,491 Disease Target Enteropeptidase 149 8 0.00 -0.97 0.05 0.53
Cancer 1,053,491 Disease Target ACAT2 145 4 0.00 -0.99 0.03 0.52
Cancer 1,053,491 Disease Drug Doxycycline Hyclate 145 4 0.00 -0.99 0.03 0.52
Cancer 1,053,491 Disease Target CXCL3 145 25 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Target Alpha-1b Adrenergic Receptor 145 2 0.00 -0.99 0.01 0.51
Cancer 1,053,491 Disease Target Glutaredoxin-1 142 3 0.00 -0.99 0.02 0.51
Cancer 1,053,491 Disease Target EPHA3 140 28 0.00 -0.89 0.20 0.56
Cancer 1,053,491 Disease Target EPHB1 137 20 0.00 -0.92 0.15 0.55
Cancer 1,053,491 Disease Target 4-1BB Ligand 135 27 0.00 -0.89 0.20 0.56
Cancer 1,053,491 Disease Target FABP3 134 7 0.00 -0.97 0.05 0.53
Cancer 1,053,491 Disease Target Proteinase-Activated Receptor 1 133 11 0.00 -0.96 0.08 0.54
Cancer 1,053,491 Disease Target Glutathione Peroxidase 3 132 25 0.00 -0.90 0.19 0.56
Cancer 1,053,491 Disease Target ACT-2 127 1 0.00 -1.00 0.01 0.49
Cancer 1,053,491 Disease Target APOC1 126 8 0.00 -0.97 0.06 0.54
Cancer 1,053,491 Disease Disease Parkinsons Disease 124 3 0.00 -0.99 0.02 0.52
Cancer 1,053,491 Disease Drug Droloxifene 123 74 0.01 -0.63 0.60 0.59
Cancer 1,053,491 Disease Target EPHB3 118 25 0.00 -0.89 0.21 0.56
Cancer 1,053,491 Disease Target COP-1 118 2 0.00 -0.99 0.02 0.51
Cancer 1,053,491 Disease Target APOA2 118 9 0.00 -0.96 0.08 0.54
Cancer 1,053,491 Disease Target Acetyl-Coa Carboxylase 1 118 7 0.00 -0.97 0.06 0.53
Cancer 1,053,491 Disease Target CALR 117 10 0.00 -0.96 0.09 0.54
Cancer 1,053,491 Disease Target CXCL10/IP-10 114 10 0.00 -0.96 0.09 0.54
Cancer 1,053,491 Disease Drug Alteplase (Activase)- FDA 112 4 0.00 -0.98 0.04 0.52
Cancer 1,053,491 Disease Drug Activase (Alteplase)- FDA 112 4 0.00 -0.98 0.04 0.52
Cancer 1,053,491 Disease Target Glutathione S-Transferase A1 111 19 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Target AACT 109 12 0.00 -0.94 0.11 0.55
Cancer 1,053,491 Disease Target Ent2 108 8 0.00 -0.96 0.07 0.54
Cancer 1,053,491 Disease Target Calcium Dependent Atpase 105 2 0.00 -0.99 0.02 0.51
Cancer 1,053,491 Disease Target Lysosomal Alpha-Glucosidase 105 3 0.00 -0.99 0.03 0.52
Cancer 1,053,491 Disease Target ANGPT2 105 14 0.00 -0.93 0.13 0.55
Cancer 1,053,491 Disease Target Apo D 105 18 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Target Lanosterol 14 Alpha-Demethylase 101 1 0.00 -1.00 0.01 0.50
Cancer 1,053,491 Disease Target Macrophage Metalloelastase 100 15 0.00 -0.92 0.15 0.55
Cancer 1,053,491 Disease Target FABP1 90 13 0.00 -0.92 0.14 0.55
Cancer 1,053,491 Disease Target APO-2L 90 44 0.00 -0.71 0.49 0.58
Cancer 1,053,491 Disease Target DEP-1 88 7 0.00 -0.96 0.08 0.54
Cancer 1,053,491 Disease Target ENO2 87 15 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Target CAPG 85 25 0.00 -0.84 0.29 0.57
Cancer 1,053,491 Disease Target Signal Transducer And Activator Of Transcription 5b 82 13 0.00 -0.92 0.16 0.55
Cancer 1,053,491 Disease Target ANGPT1 81 7 0.00 -0.96 0.09 0.54
Cancer 1,053,491 Disease Drug Doxylamine Succinate 81 1 0.00 -0.99 0.01 0.50
Cancer 1,053,491 Disease Drug Doxercalciferol 80 4 0.00 -0.97 0.05 0.53
Cancer 1,053,491 Disease Target ALPP 80 5 0.00 -0.97 0.06 0.53
Cancer 1,053,491 Disease Target Kallikrein-6 79 35 0.00 -0.75 0.44 0.58
Cancer 1,053,491 Disease Target Neuropeptide S Receptor 77 2 0.00 -0.99 0.03 0.52
Cancer 1,053,491 Disease Target CXCL7 76 12 0.00 -0.92 0.16 0.55
Cancer 1,053,491 Disease Target Actin beta 76 4 0.00 -0.97 0.05 0.53
Cancer 1,053,491 Disease Drug Drotaverine 76 1 0.00 -0.99 0.01 0.50
Cancer 1,053,491 Disease Target CD148 74 3 0.00 -0.98 0.04 0.53
Cancer 1,053,491 Disease Target Microtubule-Associated Protein 1a 73 3 0.00 -0.98 0.04 0.53
Cancer 1,053,491 Disease Target Opioid Receptor Mu 71 1 0.00 -0.99 0.01 0.51
Cancer 1,053,491 Disease Drug Aripiprazole (Abilify)- FDA 71 1 0.00 -0.99 0.01 0.51
Cancer 1,053,491 Disease Target Glutathione S-Transferase Theta-1 70 22 0.00 -0.83 0.31 0.57
Cancer 1,053,491 Disease Drug 4-Mercaptobenzoic Acid 70 4 0.00 -0.97 0.06 0.53
Cancer 1,053,491 Disease Disease Carcinoma Prostate 68 27 0.00 -0.78 0.40 0.57
Cancer 1,053,491 Disease Target ARAP 68 3 0.00 -0.98 0.04 0.53
Cancer 1,053,491 Disease Target Glutathione Peroxidase 2 67 16 0.00 -0.87 0.24 0.56
Cancer 1,053,491 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.51
Cancer 1,053,491 Disease Disease Conjunctival Disease 66 1 0.00 -0.99 0.02 0.51
Cancer 1,053,491 Disease Drug Avandia (Rosiglitazone Maleate)- FDA 66 7 0.00 -0.95 0.11 0.54
Cancer 1,053,491 Disease Target EG-VEGF 63 11 0.00 -0.91 0.17 0.55
Cancer 1,053,491 Disease Drug Adalimumab (Humira)- FDA 62 4 0.00 -0.97 0.06 0.53
Cancer 1,053,491 Disease Target CLK1 62 9 0.00 -0.92 0.15 0.55
Cancer 1,053,491 Disease Drug Abacavir Sulfate (Ziagen)- FDA 61 1 0.00 -0.99 0.02 0.51
Cancer 1,053,491 Disease Drug Kaempferide 60 8 0.00 -0.93 0.13 0.55
Cancer 1,053,491 Disease Target CCN5 57 16 0.00 -0.85 0.28 0.56
Cancer 1,053,491 Disease Target CKBB 57 4 0.00 -0.96 0.07 0.54
Cancer 1,053,491 Disease Target Apo I 55 2 0.00 -0.98 0.04 0.52
Cancer 1,053,491 Disease Drug Doxepin Hydrochloride 52 1 0.00 -0.99 0.02 0.51
Cancer 1,053,491 Disease Target Hyaluronidase-1 52 8 0.00 -0.92 0.15 0.55
Cancer 1,053,491 Disease Drug Abarelix 51 38 0.01 -0.50 0.75 0.59
Cancer 1,053,491 Disease Target ACY1 51 9 0.00 -0.91 0.18 0.55
Cancer 1,053,491 Disease Drug Acyclovir (Zovirax)- FDA 50 2 0.00 -0.98 0.04 0.52
Cancer 1,053,491 Disease Disease Carcinoma Squamous Cell 47 20 0.00 -0.76 0.43 0.57
Cancer 1,053,491 Disease Drug Azacitidine (Vidaza)- FDA 47 12 0.00 -0.86 0.26 0.56
Cancer 1,053,491 Disease Drug Aquasol A (Vitamin A)- FDA 46 4 0.00 -0.96 0.09 0.54
Cancer 1,053,491 Disease Target DNAJB1 44 4 0.00 -0.95 0.09 0.54
Cancer 1,053,491 Disease Target CD-RAP 44 5 0.00 -0.94 0.11 0.54